ClinicalTrials.gg
RecruitingNCT05634603Updated Dec 2, 2022

Efficacy of Lactose-free Milk in Treating Acute Gastroenteritis in Infants

An interventional study of Lactose-free milk formula (Frisolac LF ®) in Acute Gastroenteritis, sponsored by The Women and Children Hospital of An Giang. Recruiting at 1 site in Vietnam. Open to participants aged 2 Months to 24 Months. Per ClinicalTrials.gov, last updated 2022-12-02.

Sponsored by The Women and Children Hospital of An Giang · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 11 months ago, but the record still lists the study as recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
66
Allocation
Randomized
Ages
2 Months to 24 Months
Sex
All
01

Study summary

The purpose of this study is to determine whether lactose-free milk will change diarrhea duration and severity in formula-fed infants with acute gastroenteritis presenting to pediatric wards.

Read the detailed description

More than 525 000 children die each year due to diarrheal disease, the second leading cause of death among children under five. Children from Asian countries, including Vietnamese children, frequently have lactose intolerance. In addition, gastroenteritis, specifically rotavirus-induced gastroenteritis, temporarily impairs lactase enzymes in the intestines. In a recent Cochrane review of 33 randomized and quasi-randomized trials, lactose-free diets reduced diarrhea among children younger than 5 years old. These trials, however, involved inpatients in middle-or high-income countries. Neither patient was from a developing country, where diarrheal diseases often cause significant morbidity and mortality. The purpose of this study is to determine whether lactose-free milk will change the duration and severity of diarrhea in Vietnamese infants with acute gastroenteritis.

02

Conditions studied

  • Acute Gastroenteritis

Browse trials for

Keywords

  • diarrhea lactose-free diet
03

In context

Gastroenteritis

237 studies on the registry are indexed under Gastroenteritis; 16 are open to participants now.

This study's planned enrollment of 66 is below the median of 136 across 164 interventional studies indexed under Gastroenteritis.

Browse Gastroenteritis studies →

Lead sponsor

This is the only study on the registry with The Women and Children Hospital of An Giang as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
2 Months to 24 Months
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children 2- 24 months old on artificial milk formula
  • Acute diarrhea (3 or more loose or liquid stools per day)

Exclusion criteria

Exclusion Criteria:

  • Used antibiotics within 3 days before admission
  • Breastfeeding
  • Severe dehydration, defined by a need of IV rehydration
  • Malnutrition (weight/height\< -3SD)
  • Chronic underlying disease, condition or systemic infection
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
66 participants (estimated)

Study arms

  • Active comparator
    Intervention

    Lactose-free milk formula (Frisolac LF ®)

    Dietary Supplement: Lactose-free milk formula (Frisolac LF ®)

  • Placebo comparator
    Placebo

    Regular infant milk formula

    Dietary Supplement: Lactose-free milk formula (Frisolac LF ®)

Interventions

  • Dietary supplementLactose-free milk formula (Frisolac LF ®)

    Following the initial rehydration phase, children were alternately assigned to receive 100 ml/kg/day of either lactose-free or lactose-containing formula

06

What researchers measure

Primary outcomes

  1. Change in diarrhea duration

    llness onset and last diarrhoeal stool (the number of days with 3 or more loose or watery stools)

    Time frame: 7 days

Secondary outcomes

  1. Weight gain

    Time frame: 7 days

  2. Severity of diarrhea according to the modified Vesikari score

    Time frame: 7 days

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • MacGillivray S, Fahey T, McGuire W. Lactose avoidance for young children with acute diarrhoea. Cochrane Database Syst Rev. 2013 Oct 31;2013(10):CD005433. doi: 10.1002/14651858.CD005433.pub2. PubMed 24173771 ↗
  • Simakachorn N, Tongpenyai Y, Tongtan O, Varavithya W. Randomized, double-blind clinical trial of a lactose-free and a lactose-containing formula in dietary management of acute childhood diarrhea. J Med Assoc Thai. 2004 Jun;87(6):641-9. PubMed 15279342 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 2, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05634603
Lead sponsor
The Women and Children Hospital of An Giang
Collaborators
Can Tho University of Medicine and Pharmacy
Responsible party
Rang Nguyen (University of Medicine and Pharmacy of Can Tho, The Women and Children Hospital of An Giang) — Principal investigator
First posted
Dec 2, 2022
Start date
Dec 1, 2022 (estimated)
Primary completion
Dec 1, 2024 (estimated)
Completion
Apr 30, 2025 (estimated)
Last update
Dec 2, 2022

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion